Search Result "tofogliflozin."
Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study
Journal: Current Vascular Pharmacology
Volume: 17 Issue: 4 Year: 2019 Page: 411-420
Author(s): Munehisa Bekki,Nobuhiro Tahara,Atsuko Tahara,Sachiyo Igata,Akihiro Honda,Yoichi Sugiyama,Tomohisa Nakamura,Jiahui Sun,Yuki Kumashiro,Takanori Matsui,Yoshihiro Fukumoto,Sho-ichi Yamagishi
Recent Developments in Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors as a Valuable Tool in the Treatment of Type 2 Diabetes Mellitus
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 20 Issue: 3 Year: 2020 Page: 170-182
Author(s): Shubham Kumar,Gopal L. Khatik,Amit Mittal
SodiumâGlucose Co-Transporters Inhibitors for Type 2 Diabetes Mellitus: The âNew Kids on the Blockâ in the Era of Evidence-based Medicine
Ebook: Frontiers in Clinical Drug Research-Diabetes and Obesity
Volume: 4 Year: 2019
Author(s): Cheow Peng Ooi,Norlaila Mustafa,Nor Azmi Kamaruddin,Munn Sann Lye
Doi: 10.2174/9781681084459119040005
Design of SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: A History Driven by Biology to Chemistry
Journal: Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2015 Page: 317-328
Author(s): Wenqing Cai,Linlin Jiang,Yafei Xie,Yuqiang Liu,Wei Liu,Guilong Zhao
Recent Developments of C-Aryl Glucoside SGLT2 Inhibitors
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 8 Year: 2016 Page: 832-849
Author(s): Yang Zhang, Zhao-Peng Liu
Canagliflozin : A New Hope in the Antidiabetic Armamentarium
Journal: Recent Patents on Cardiovascular Drug Discovery
Volume: 8 Issue: 3 Year: 2013 Page: 216-220
Author(s): Vasiliki K. Katsi,Christos A. Michalakeas,Charalambos E. Grassos,Georgia D. Vamvakou,John P. Lekakis,Dimitris Tousoulis,Christodoulos I. Stefanadis,Thomas K. Makris,Ioannis E. Kallikazaros
Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?
Journal: Current Vascular Pharmacology
Volume: 14 Issue: 6 Year: 2016 Page: 494-497
Author(s): Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis
Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 3 Year: 2018 Page: 219-227
Author(s): Niki Katsiki,Pablo Perez-Martinez,Panagiotis Anagnostis,Dimitri P. Mikhailidis,Asterios Karagiannis
SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 10 Year: 2017 Page: 1510-1521
Author(s): Konstantinos Imprialos,Charles Faselis,Chrysoula Boutari,Konstantinos Stavropoulos,Vasilios Athyros,Asterios Karagiannis,Michael Doumas
Studying Interactions of Drugs with Cell Membrane Nutrient Transporters: New Frontiers of Proteoliposome Nanotechnology
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 26 Year: 2017 Page: 3871-3883
Author(s): Mariafrancesca Scalise,Michele Galluccio,Lorena Pochini,Lara Console,Maria Barile,Nicola Giangregorio,Annamaria Tonazzi,Cesare Indiveri